Skip to main content

Table 1 Pulmonary Physiologic Characteristics and Pulmonary Hypertension Characteristics in 32 patients with IPAH.

From: Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension

MEF75, % predicted

80.0 ± 20.4

MEF50, % predicted

65.0 ± 25.4

MEF25, % predicted

44.5 ± 23.6

VC, % predicted

90.2 ± 19.8

FEV1, % predicted

85.5 ± 15.8

Rtot, kPa × s × L-1

0.3 ± 0.2

RV, % predicted

109.8 ± 21.4

TLC, % predicted

95.6 ± 12.5

sPAP, mmHg

79.4 ± 19.1

6-MWT, m

363.8 ± 125.2

NT-proBNP, ng/L

1427 ± 2162.7

  1. 6-MWT = six minute walk test; FEV1 = forced expiratory volume within first second; MEF75, 50, 25 = maximal expiratory flow at 75%, 50%, 25% of remaining VC; NT-proBNP = N-terminal-pro-B-type natriuretic peptide serum level; RV = residual volume, Rtot = airway resistance; sPAP = systolic pulmonary artery pressure as determined from tricuspid regurgitation velocitiy during echocardiography, TLC = total lung capacity, VC = vital capacity. Data are presented as mean ± SD.